Clinical Trials Directory

Trials / Completed

CompletedNCT02117960

Assessing the Effects of Omega-3 Supplementation on Serum HSP27, HSP70, YKL40, BMP-4 Levels in Male Patient With CAD

Assessing the Effects of Omega-3 Supplementation on Serum HSP27, HSP70, YKL40, BMP-4 Levels in Male Patient With Coronary Artery Disease

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Tehran University of Medical Sciences · Academic / Other
Sex
Male
Age
45 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is the comparison between the effects of supplementation with omega 3 or placebo for 8 weeks in serum level of BMP-4, YKL40, HSP70, HSP27 in patients with cardiovascular disease.

Detailed description

The aim of this study is the comparison between the effects of supplementation with omega 3 or placebo for 8 weeks in serum level of BMP-4, YKL40, HSP70, HSP27 in patients with cardiovascular disease. In this randomized, double-blind clinical trial, placebo-controlled, single-center, and phase two trials, 42men aged 45-65 years with Coronary Artery Disease are enrolled in the study from Tehran Heart Center. After signing informed consent all individuals complete a general information form , 24-hour food recall for 3 days will be taken from the participants at the beginning and the end of the study,. Selected samples are randomly classified into 2 blocks of groups receiving supplement and placebo. The supplement group, will receive 4 g/day omega 3 fatty acid for 8 weeks and the placebo group will also receive placebo (containing 4 g of edible paraffin) (similar in terms of color, shape and size). Patients are recommended to sustain their diets and medication dose (s) during the study and also advised to maintain a constant level of physical activity. Blood samples will be collected after 8-12 hours fasting and anthropometric variables, biochemical parameters and physical activity before and after the trial will be measured.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOmega-34 cap 1 g Omega-3 per day for 2 months
DIETARY_SUPPLEMENTPlacebo4 cap 1 g Placebo(paraffin) per day for 2 months

Timeline

Start date
2011-12-01
Primary completion
2013-08-01
Completion
2013-10-01
First posted
2014-04-21
Last updated
2015-04-08

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT02117960. Inclusion in this directory is not an endorsement.